130 related articles for article (PubMed ID: 1387924)
1. Presynaptic serotonin mechanisms in rats subjected to inescapable shock.
Edwards E; Kornrich W; Houtten PV; Henn FA
Neuropharmacology; 1992 Apr; 31(4):323-30. PubMed ID: 1387924
[TBL] [Abstract][Full Text] [Related]
2. Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression.
Edwards E; Harkins K; Wright G; Henn F
J Neurochem; 1991 May; 56(5):1581-6. PubMed ID: 1826517
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1b receptors in an animal model of depression.
Edwards E; Harkins K; Wright G; Henn FA
Neuropharmacology; 1991 Jan; 30(1):101-5. PubMed ID: 2046876
[TBL] [Abstract][Full Text] [Related]
4. In vitro neurotransmitter release in an animal model of depression.
Edwards E; Kornrich W; van Houtten P; Henn FA
Neurochem Int; 1992 Jul; 21(1):29-35. PubMed ID: 1303140
[TBL] [Abstract][Full Text] [Related]
5. Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes.
Gleiter CH; Nutt DJ
Psychopharmacology (Berl); 1988; 95(1):68-70. PubMed ID: 2838861
[TBL] [Abstract][Full Text] [Related]
6. Monoamine receptors in an animal model of affective disorder.
Martin JV; Edwards E; Johnson JO; Henn FA
J Neurochem; 1990 Oct; 55(4):1142-8. PubMed ID: 1697887
[TBL] [Abstract][Full Text] [Related]
7. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
Dewar KM; Reader TA; Grondin L; Descarries L
Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
[TBL] [Abstract][Full Text] [Related]
8. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
De Souza EB; Kuyatt BL
Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
[TBL] [Abstract][Full Text] [Related]
10. In vivo labeling of serotonin uptake sites with [3H]paroxetine.
Scheffel U; Hartig PR
J Neurochem; 1989 May; 52(5):1605-12. PubMed ID: 2523469
[TBL] [Abstract][Full Text] [Related]
11. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
Dewar KM; Grondin L; Carli M; Lima L; Reader TA
J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
[TBL] [Abstract][Full Text] [Related]
12. Serotonin and learned helplessness: a regional study of 5-HT1A, 5-HT2A receptors and the serotonin transport site in rat brain.
Wu J; Kramer GL; Kram M; Steciuk M; Crawford IL; Petty F
J Psychiatr Res; 1999; 33(1):17-22. PubMed ID: 10094235
[TBL] [Abstract][Full Text] [Related]
13. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
Galzin AM; Moret C; Verzier B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
[TBL] [Abstract][Full Text] [Related]
14. Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat.
Moret C; Briley M
Psychiatry Res; 1991 Aug; 38(2):97-104. PubMed ID: 1836639
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?
Scheffel U; Ricaurte GA
Brain Res; 1990 Sep; 527(1):89-95. PubMed ID: 1980843
[TBL] [Abstract][Full Text] [Related]
16. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
Graham D; Esnaud H; Habert E; Langer SZ
Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
[TBL] [Abstract][Full Text] [Related]
17. Characterization of [3H]paroxetine binding in rat brain.
Marcusson JO; Bergström M; Eriksson K; Ross SB
J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic lithium treatment on 5-hydroxytryptamine autoreceptors and release of 5-[3H]hydroxytryptamine from rat brain cortical, hippocampal, and hypothalamic slices.
Friedman E; Wang HY
J Neurochem; 1988 Jan; 50(1):195-201. PubMed ID: 2826685
[TBL] [Abstract][Full Text] [Related]
19. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
Plenge P; Mellerup ET; Laursen H
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
[TBL] [Abstract][Full Text] [Related]
20. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME
Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]